9403 Eribulin mesylate (E7389) in patients with leiomyosarcoma (LMS) and other (OTH) subtypes of soft tissue sarcoma (STS): a Phase II study from the European Organisation for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (EORTC 62052)
Keyword(s):
Phase Ii
◽
2007 ◽
Vol 43
(2)
◽
pp. 308-315
◽
2014 ◽
Vol 50
(2)
◽
pp. 388-396
◽